AstraZeneca has announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the deve...
The global Neurorehabilitation Devices Market is foreseen to project a notable growth because of the rising pr...
The U.S. Food and Drug Administration, on 27 August 2019, approved Nourianz (istradefylline) tablets as an add-on treatm...
KPMG's Clinical Intelligence (KCI) platform is helping clinicians improve the quality of care by furnishing them with ph...
Masimo, on 27 August 2019, announced the latest publication of a report on 150 randomized controlled trials of ICU ...
Agilent Technologies has announced it has completed the acquisition of BioTek Instruments, a global leader in the design...
Drawbridge Health, Founded in 2015 by GE Ventures and GE Healthcare, Drawbridge Health is a healthcare technology c...
Bristol-Myers Squibb Company has announced that Celgene Corporation in connection with its merger agreement with B...
Gilead Sciences and Galapagos have announced the closing of the global research and development collaboration agreement ...
Myomo, Inc. is a wearable medical robot company that provides greater mobility for people with neurological disorders an...
Suncoast Neuroscience Associates is recruiting for a clinical research study to evaluate an investigational medication i...
Themis Bioscience has announced a research collaboration and exclusive license agreement with MSD (tradename o...
The "Asia Pacific Cardiovascular Devices Market to 2027 - Regional Analysis and Forecasts By Device, Pacemaker, Ste...
Rexgenero, a regenerative medicine company based in Spain pioneering the development of advanced cell-based therapies to...
Belgium based Miracor Medical SA (Miracor Medical) has been granted Breakthrough Device Designation by the U.S. Food and...
The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) have announced positive top-line results fr...
Boston Scientific Corporation has announced the U.S. Food and Drug Administration (FDA) approval of its ImageReady&trade...
The generic drugs market is estimated to have reached $257.3bn in 2018 and is expected to grow at a CAGR of 8....
